ALEMBIC PHARMACEUTICALS LTD SHARE PRICE [LIVE]

  
NSE: APLLTD
588.15
BSE: 533573
589.50
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality

Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
-25.87%
Sector
-6.33%
Sensex
8.32%
Underperformed both Sector by -19.54% and Sensex by -34.19%
IndustryPharma
MARKET CAP (Mid Cap Stock)Rs 11,538 Cr
PE (TTM) 41.60
DIVIDEND YIELD 1.69%
PE Ratio41.60
Price to Book Value2.27
EV to EBIT36.73
EV to EBITDA18.98
EV to Capital Employed2.12
EV to Sales2.27
PEG Ratio0.00
Dividend Yield1.69%
ROCE (Latest)5.76%
ROE (Latest)5.46%
NameSep 22Jun 22
Promoters (Change:-0.00) 69.61%69.61%
FIIs (Change:-0.62) 5.32%5.94%
Mutual Funds (Change:0.35) 5.36%5.01%
Insurance Companies (Change:0.02) 7.03%7.01%
Other DIIs (Change:0.03) 0.15%0.12%
Non Institution (Change:0.23) 12.53%12.3%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in ALEMBIC PHARMACEUTICALS LTD

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

APLLTD News

Frequently Asked Questions

What is the Share price of ALEMBIC PHARMACEUTICALS LTD. (APLLTD)?

ALEMBIC PHARMACEUTICALS LTD. (APLLTD) share price as of December 7, 2022, on NSE is Rs 588.15 (NSE) and Rs 589.50 (BSE) on BSE.

Can I buy ALEMBIC PHARMACEUTICALS LTD. (APLLTD) shares?

Yes, You can buy ALEMBIC PHARMACEUTICALS LTD. (APLLTD) shares by opening a Demat account with Angel One.

How do I buy ALEMBIC PHARMACEUTICALS LTD. (APLLTD) from Angel One?

ALEMBIC PHARMACEUTICALS LTD. (APLLTD) share can be brought through the following modes:
  1. Direct investment: You can buy ALEMBIC PHARMACEUTICALS LTD. (APLLTD) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to ALEMBIC PHARMACEUTICALS LTD. (APLLTD) shares.

In which sector do ALEMBIC PHARMACEUTICALS LTD. (APLLTD) belong?

ALEMBIC PHARMACEUTICALS LTD. (APLLTD) belongs to Pharma.

About APLLTD

Today's live share price for ALEMBIC PHARMACEUTICALS LTD is NSE: ₹ 588.15, BSE: ₹ 589.50 with a current market capitalization of .

Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in Pharamceulicals business. As per the scheme of arrangement, the "Pharmaceutical Undertaking" of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement, the shareholding of Alembic Ltd in the company reduced from 100% to 29.18%. Thus, the company became an associate of Alembic Ltd. In September 20, 2011, the equity shares of the company were listed on the Bombay Stock Exchange and National Stock Exchange. During 2012, Alembic and Breckenridge Announced Paragraph IV ANDA Litigation with Pfizer on Desvenlafaxine (Pristiq). The company enters into a product development and license agreement with Accu-Break Pharmaceuticals, Inc, USA. During 2013, the company got USFDA approval for its NDA - Desvenlafaxine Base Extended Release Tablets and also entered into an out-licensing agreement with Ranbaxy Pharmaceuticals Inc (Ranbaxy) to market its product in USA. During 2014, the company announces joint venture with Adwiya Mami SARL Algeria through its wholly owned Subsidiary - Alembic Global Holding S.A.". During 2015, the companies associate signs exclusive agreement with Novartis.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers